- Regular updates
- No spam
You are here
Spin-off launched in protein bio-markers
The Flanders Interuniversity Institute for Biotechnology (VIB) and Ghent University have launched a biopharmaceutical company named Peakadilly, the two organizations have announced in a media statement.
The company will develop and market a new generation of molecular diagnostics − so-called protein bio-markers − using innovative proteomics technology developed by a research group under the direction of Joël Vandekerckhove.
The markers can be used in the development of medicines, making the process much more efficient, effective and economical. They will also enable doctors to detect diseases sooner and, because many medicines work effectively only with a limited group of patients, doctors will also be able to verify whether a particular medicine will work for certain individuals.
Peakadilly will be led by Koen Kas, who has been closely involved in the development of the technology platform.
Reported by
FIT28 October 2004
More news about Flanders?
Interested in doing business in Flanders?
Let us help you!
- We can introduce you to other companies, banks and regulators
- We organize site visits to real estate locations
- We assist with all legal aspects of setting up a business
- We're an official government agency
- Our services are completely free
- We are a team of international experts
Receive our handbook to growing your business in Flanders
- It's completely free.
- Get an overview of all incentives relevant to your company.
- Tax system explained in-depth.
- Learn how to set up your business quickly.
- Discover the benefits of Flanders (in addition to the chocolate).
